SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Introgen Therapeutics
An SI Board Since February 2004
Posts SubjectMarks Bans Symbol
802 21 0 INGN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
27aacr04.agora.com this is an abstract about ad-interferon preclinicals that Paglzeta19613/23/2004
26Here's the abstract on the Delta 24 construct which will be presented at AACzeta19613/22/2004
25p53 woes.... Hi Tuck... I'll give you a nurse's persepective of the &qzeta19613/22/2004
24A more recent abstract from Pagliaro's group tests ADVEXIN in combo with cistuck3/20/2004
23This letter and reply from a recent issue of JCO concerns me a bit: jco.org &qtuck3/19/2004
22INGN up 14% on news of discontinuation of follow-on... have a great w/e all... zeta19613/19/2004
21Maybe it would be a good idea to take it over to the valuation people. My only ttom pope3/19/2004
20<<Your INGN leads an eventful life:>> How true, how true...back in zeta19613/19/2004
19Your INGN leads an eventful life: <i>07:14 ET Introgen withdraws common stom pope3/19/2004
18Hi Tom, I have the same headline, from DJ newswire. Thanks for the heads up. SnowShredder3/18/2004
17It was on the ML site, which has a news feed of headlines - but once the headlintom pope3/18/2004
16Thanks Tom...where did you find this? We INGN investors have been waiting for tzeta19613/18/2004
15I don't follow INGN but I stumbled on this, seems to be relevant to this thrtom pope3/18/2004
14Just parking some older information regarding gene therapy oversight. Regulatiozeta19613/16/2004
13Ingn will be attending SG Cowen on 3/10/04 They'd taken it off their websitzeta19613/9/2004
12Oh, no problem Tuck... This has turned out to be a long one...as I'm wrappizeta19613/7/2004
11Sorry to be so slow in responding. I've been busier than usual, and expect tuck3/6/2004
10You're welcome Snow... I couldn't find any clinical data papers...don&#zeta19613/6/2004
9Hi Zeta, Thanks for doing some leg work(I guess I have a lot of reading to do).SnowShredder3/6/2004
8AACR dates: March 27-31, 2004 Some more abstracts...some directly INGN, others zeta19613/5/2004
7AACR abstracts are out...these are primarily related to mda7 aacr04.agora.com zeta19613/5/2004
6what was your take of the recent CC? happy Oscar night Zetazeta19612/29/2004
5Some recently published INGN patents finance.messages.yahoo.comzeta19612/22/2004
4Tuck,Wouldn't one of INGN's Advexin trials with brocho-alveolar adminiszeta19612/19/2004
3>>Mol Cancer Ther. 2004;3:93-100 © 2004 American Association for Canctuck2/19/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News